{"id":46523,"date":"2022-07-25T16:03:05","date_gmt":"2022-07-25T14:03:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/"},"modified":"2022-07-25T16:03:05","modified_gmt":"2022-07-25T14:03:05","slug":"the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/","title":{"rendered":"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5624362\/viral-vector-and-plasmid-dna-manufacturing-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=qjcrdl&amp;utm_campaign=1730434+-+The+Worldwide+Viral+Vector+%26+Plasmid+DNA+Manufacturing+Industry+is+Projected+to+Reach+%243.2+Billion+by+2027&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Viral Vector &amp; Plasmid DNA Manufacturing Market Intelligence Report &#8211; Global Forecast to 2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220725005586\/en\/1522942\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220725005586\/en\/1522942\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Viral Vector &amp; Plasmid DNA Manufacturing Market is projected to reach USD 3,296.84 million by 2027 from USD 860.08 million in 2021, at a CAGR 25.10% during the forecast period.\n<\/p>\n<p>\n<strong>Market Statistics:<\/strong>\n<\/p>\n<p>\nThe report provides market sizing and forecast across 7 major currencies &#8211; USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.\n<\/p>\n<ul>\n<li>\nThe Americas Viral Vector &amp; Plasmid DNA Manufacturing Market size was estimated at USD 311.42 million in 2021 and expected to reach USD 388.54 million in 2022, at a CAGR 25.01% to reach USD 1,189.03 million by 2027.\n<\/li>\n<li>\nThe Asia-Pacific Viral Vector &amp; Plasmid DNA Manufacturing Market size was estimated at USD 248.66 million in 2021 and expected to reach USD 312.08 million in 2022, at a CAGR 25.27% to reach USD 961.36 million by 2027.\n<\/li>\n<li>\nThe Europe, Middle East &amp; Africa Viral Vector &amp; Plasmid DNA Manufacturing Market size was estimated at USD 299.99 million in 2021 and expected to reach USD 374.45 million in 2022, at a CAGR 25.03% to reach USD 1,146.43 million by 2027.\n<\/li>\n<\/ul>\n<p>\n<strong>Market Segmentation &amp; Coverage:<\/strong>\n<\/p>\n<p>\nThis research report categorizes the viral vector &amp; plasmid DNA manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:\n<\/p>\n<p>\n<strong>Cell Line:<\/strong>\n<\/p>\n<ul>\n<li>\nIn-vitro\n<\/li>\n<li>\nIn-Vivo\n<\/li>\n<\/ul>\n<p>\n<strong>Type:<\/strong>\n<\/p>\n<ul>\n<li>\nAdeno-Associated Virus\n<\/li>\n<li>\nAdenovirus\n<\/li>\n<li>\nLentivirus\n<\/li>\n<li>\nPlasmid DNA\n<\/li>\n<\/ul>\n<p>\n<strong>Transfection:<\/strong>\n<\/p>\n<ul>\n<li>\nStable Transfection\n<\/li>\n<li>\nTransient Transfection\n<\/li>\n<\/ul>\n<p>\n<strong>Indication:<\/strong>\n<\/p>\n<ul>\n<li>\nCancer\n<\/li>\n<li>\nGenetic Disorder\n<\/li>\n<li>\nInfectious Disease\n<\/li>\n<\/ul>\n<p>\n<strong>Workflow:<\/strong>\n<\/p>\n<ul>\n<li>\nDownstream Processing<\/p>\n<ul>\n<li>\nFill-finish\n<\/li>\n<li>\nPurification\n<\/li>\n<\/ul>\n<\/li>\n<li>\nUpstream Processing<\/p>\n<ul>\n<li>\nVector Amplification &amp; Expansion\n<\/li>\n<li>\nVector Recovery\/Harvesting\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\n<strong>Application:<\/strong>\n<\/p>\n<ul>\n<li>\nAntisense &amp; RNAi\n<\/li>\n<li>\nCell Therapy\n<\/li>\n<li>\nGene Therapy\n<\/li>\n<li>\nVaccinology\n<\/li>\n<\/ul>\n<p>\n<strong>End User:<\/strong>\n<\/p>\n<ul>\n<li>\nBiotech Companies\n<\/li>\n<li>\nResearch Institutes\n<\/li>\n<\/ul>\n<p>\n<strong>Region:<\/strong>\n<\/p>\n<ul>\n<li>\nAmericas<\/p>\n<ul>\n<li>\nArgentina\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nUnited States\n<\/li>\n<\/ul>\n<\/li>\n<li>\nAsia-Pacific<\/p>\n<ul>\n<li>\nAustralia\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nIndonesia\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nMalaysia\n<\/li>\n<li>\nPhilippines\n<\/li>\n<li>\nSingapore\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nTaiwan\n<\/li>\n<li>\nThailand\n<\/li>\n<\/ul>\n<\/li>\n<li>\nEurope, Middle East &amp; Africa<\/p>\n<ul>\n<li>\nFrance\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nNetherlands\n<\/li>\n<li>\nQatar\n<\/li>\n<li>\nRussia\n<\/li>\n<li>\nSaudi Arabia\n<\/li>\n<li>\nSouth Africa\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nUnited Arab Emirates\n<\/li>\n<li>\nUnited Kingdom\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\n<strong>Company Usability Profiles:<\/strong>\n<\/p>\n<ul>\n<li>\nABL Inc.\n<\/li>\n<li>\nBatavia Biosciences B.V.\n<\/li>\n<li>\nBioNTech IMFS GmbH\n<\/li>\n<li>\nBiovian Oy\n<\/li>\n<li>\nc-LEcta GmbH\n<\/li>\n<li>\nCell and Gene Therapy Catapult\n<\/li>\n<li>\nCevec Pharmaceuticals GmbH\n<\/li>\n<li>\nCobra Biologics Limited\n<\/li>\n<li>\nCreative Biogene\n<\/li>\n<li>\nFinVector Vision Therapies\n<\/li>\n<li>\nFUJIFILM Diosynth Biotechnologies Inc.\n<\/li>\n<li>\nGE Healthcare\n<\/li>\n<li>\nGeneOne Life Science, Inc.\n<\/li>\n<li>\nGenezen Laboratories\n<\/li>\n<li>\nKaneka Eurogentec S.A.\n<\/li>\n<li>\nLonza Group AG\n<\/li>\n<li>\nMerck KGaA\n<\/li>\n<li>\nMiltenyi Biotec GmbH\n<\/li>\n<li>\nNovasep Inc.\n<\/li>\n<li>\nSirion-Biotech GmbH\n<\/li>\n<li>\nSpark Therapeutics Inc.\n<\/li>\n<li>\nThermo Fisher Scientific Inc.\n<\/li>\n<li>\nuniQure N.V.\n<\/li>\n<li>\nVigene Biosciences, Inc.\n<\/li>\n<li>\nWuxi AppTec Co., Ltd.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5624362\/viral-vector-and-plasmid-dna-manufacturing-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=qjcrdl&amp;utm_campaign=1730434+-+The+Worldwide+Viral+Vector+%26+Plasmid+DNA+Manufacturing+Industry+is+Projected+to+Reach+%243.2+Billion+by+2027&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/h01txh<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;&#58;&#112;res&#x73;&#x40;&#x72;&#x65;&#x73;&#101;&#97;&#114;cha&#x6e;&#x64;&#x6d;&#x61;&#x72;&#107;&#101;&#116;s&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#114;&#x65;&#x73;&#115;&#64;&#x72;&#x65;&#115;&#101;&#x61;&#x72;&#99;&#104;&#x61;&#x6e;&#100;&#109;&#x61;&#x72;&#107;&#101;&#x74;&#x73;&#46;&#99;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Viral Vector &amp; Plasmid DNA Manufacturing Market Intelligence Report &#8211; Global Forecast to 2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Viral Vector &amp; Plasmid DNA Manufacturing Market is projected to reach USD 3,296.84 million by 2027 from USD 860.08 million in 2021, at a CAGR 25.10% during the forecast period. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46523","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Viral Vector &amp; Plasmid DNA Manufacturing Market Intelligence Report &#8211; Global Forecast to 2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Viral Vector &amp; Plasmid DNA Manufacturing Market is projected to reach USD 3,296.84 million by 2027 from USD 860.08 million in 2021, at a CAGR 25.10% during the forecast period. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-25T14:03:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220725005586\/en\/1522942\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-25T14:03:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/\"},\"wordCount\":482,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005586\\\/en\\\/1522942\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/\",\"name\":\"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005586\\\/en\\\/1522942\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-25T14:03:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005586\\\/en\\\/1522942\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220725005586\\\/en\\\/1522942\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Viral Vector &amp; Plasmid DNA Manufacturing Market Intelligence Report &#8211; Global Forecast to 2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Viral Vector &amp; Plasmid DNA Manufacturing Market is projected to reach USD 3,296.84 million by 2027 from USD 860.08 million in 2021, at a CAGR 25.10% during the forecast period. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-25T14:03:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220725005586\/en\/1522942\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 &#8211; ResearchAndMarkets.com","datePublished":"2022-07-25T14:03:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/"},"wordCount":482,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220725005586\/en\/1522942\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/","name":"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220725005586\/en\/1522942\/21\/logo.jpg","datePublished":"2022-07-25T14:03:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220725005586\/en\/1522942\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220725005586\/en\/1522942\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-viral-vector-plasmid-dna-manufacturing-industry-is-projected-to-reach-3-2-billion-by-2027-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The Worldwide Viral Vector &amp; Plasmid DNA Manufacturing Industry is Projected to Reach $3.2 Billion by 2027 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46523"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46523\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}